Phase 1 clinical trial of unique COVID-19 vaccine begins
Mouse models of neurodevelopmental disorders display metabolic dysfunction
5 April 2021Unique mini-microscope provides insight into complex brain functions
5 April 2021Phase 1 clinical trial of unique COVID-19 vaccine begins
A unique vaccine to protect against COVID-19 begins clinical testing Tuesday, 6 April, at the Walter Reed Army Institute of Research (WRAIR), part of the U.S. Army Medical Research and Development Command. Scientists developed a nanoparticle vaccine, based on a ferritin platform, which offers a flexible approach to targeting multiple variants of SARS-COV-2 and potentially other coronaviruses as well.
